Steven M. Paul

Former Venture Partner at Third Rock Ventures LLC

Steven M. Paul

Steven M. Paul

Former Venture Partner at Third Rock Ventures LLC

Overview
Career Highlights

The American College of Neuropsychopharmacology, Inc.
Lilly Research Laboratories
Eli Lilly & Company

RelSci Relationships

8963

Number of Boards

31

Birthday

1951

Age

69

Number of Awards

3

Contact Data
Trying to get in touch with Steven M. Paul? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Steven M. Paul likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at PureTech Health PLC

Relationship likelihood: Strong

Co-Founder at PureTech Health PLC

Relationship likelihood: Strong

Chief Business Officer at Akili Interactive Labs, Inc.

Relationship likelihood: Strong

Co-Founder at Third Rock Ventures LLC

Relationship likelihood: Strong

Founder at Kew, Inc.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at SAGE Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Karuna Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Verity BioConsulting LLC

Relationship likelihood: Strong

Co-Founder at Third Rock Ventures LLC

Relationship likelihood: Strong

Chief Executive Officer at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Steven M. Paul
Potential Connections via
Relationship Science
You
Steven M. Paul
Former Venture Partner at Third Rock Ventures LLC
Family Members
Education
MS
Class of 1975
Memberships
Fellow
2009 - Current

The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC.

Member
Current

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Member
Current

Alpha Omega Alpha supports many programs for medical students and physicians at our 123 chapters, and publishes a quarterly journal, The Pharos, which contains articles on nontechnical medical subjects, including history, ethics, national issues, personal essays, and poetry.

Career History
Chairman of the Board, President & Chief Executive Officer
2018 - Current

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders.The company was founded in July 2009 by Andrew Miller, Eric Elenko and Peter Jeffrey Conn and is headquartered in Boston, MA.

Co-Founder
2011 - Current

Tal Medical, Inc. operates as a clinical stage medical device company. It develops novel, non contact, neuromodulatory devices for the treatment of psychiatric and neurological disorders. The firm focuses on the development of LFMS for the treatment of major depressive disorder and bipolar depression. The company was founded by Daphne Zohar, Steven Marc Paul, Andrew Miller, Eric Elenko and Nessan Bermingham in 2010 and is headquartered in Boston, MA.

Venture Partner
2010 - Current

Third Rock Ventures invests in companies located in the US. The firm targets operating in the fields of healthcare sector. It provides financing for early-stage capital requirements. It also acts as a lead investor.

Boards & Committees
Member, Board of Directors
Prior
Director
Tenure Unconfirmed
Transactions
Details Hidden

Voyager Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Tal Medical, Inc. raised money in a private placement transaction

Details Hidden

Eli Lilly & Company purchases Hypnion, Inc.

Investments
Details Hidden

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders.The company was founded in July 2009 by Andrew Miller, Eric Elenko and Peter Jeffrey Conn and is headquartered in Boston, MA.

Details Hidden

SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.

Details Hidden

Tal Medical, Inc. operates as a clinical stage medical device company. It develops novel, non contact, neuromodulatory devices for the treatment of psychiatric and neurological disorders. The firm focuses on the development of LFMS for the treatment of major depressive disorder and bipolar depression. The company was founded by Daphne Zohar, Steven Marc Paul, Andrew Miller, Eric Elenko and Nessan Bermingham in 2010 and is headquartered in Boston, MA.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
Board Certification - American Board of Psychiatry and Neurology
A. E. Bennett Award
Arthur S. Flemming Award
Events
Speaker
New York City, NY
4th Annual Partnering for Cures

Partnering for Cures is FasterCures' annual meeting that brings together diverse participants to discuss and solve the crucial issues facing the medical research world today. Partnering for Cures is structured with thought-provoking panels that host well-known speakers from the different sectors of the medical world; presenters from organizations that are boasting innovative approaches to the issues facing health; pro-bono, personalized advice from experts across medical research fields; and a unique partnering systems that allows conference participants to schedule meetings throughout the weekend to collaborate and create new approaches to save and improve lives.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Steven M. Paul. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Steven M. Paul's profile does not indicate a business or promotional relationship of any kind between RelSci and Steven M. Paul.